Go to content
UR Home

Pharmacokinetics of recombinant human erythropoietin applied subcutaneously to children with chronic renal failure

URN to cite this document:
urn:nbn:de:bvb:355-epub-269404
Braun, A. ; Ding, R. ; Seidel, C. ; Fies, T. ; Kurtz, Armin ; Schärer, K.
[img]
Preview
PDF
(505kB)
Date of publication of this fulltext: 11 Dec 2012 08:56


Abstract

The single-dose pharmacokinetics of recombinant human erythropoietin (rHuEPO) given SC was investigated in 20 patients aged 7-20 years at different stages of chronic renal failure. In a pilot study we confirmed the lower bioavailability of the drug in 2 children when given SC compared with the IV route (24% and 43%, respectively). Following administration of 4,000 units/m2, rHuEPO SC effective ...

plus


Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons